SENORESBSESENORES PHARMACEUTICALS LLowNeutral
Announced Tue, 21 Jul · 16:17 IST

Senores Pharma schedules Q1FY27 earnings call on July 27, 2026

Board & Shareholder Meetings View source PDF

SENORES · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-0.2%1-day move
₹1406.00
prior close
₹1419.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.9-1.5-2.5-0.7-0.2-1.3-0.6
Up moveDown movePending
AI summary

Senores Pharmaceuticals has informed BSE and NSE that it will hold an earnings conference call for Q1FY27 on Monday, July 27, 2026 at 5:15 PM IST, after announcing unaudited consolidated and standalone results for the quarter ended June 30, 2026. The call is hosted by DAM Capital Advisors. Management speakers include MD Swapnil Shah, Chairman Sanjay Majmudar, and Whole-Time Director and CFO Deval Shah. The audio recording and transcript will be posted on the company website afterwards.

Likely market impact

Routine scheduling update. Investors can join the call for management commentary on Q1FY27 results and outlook. No material corporate action.